Literature DB >> 10761930

Targeted overactivity of beta cell K(ATP) channels induces profound neonatal diabetes.

J C Koster1, B A Marshall, N Ensor, J A Corbett, C G Nichols.   

Abstract

A paradigm for control of insulin secretion is that glucose metabolism elevates cytoplasmic [ATP]/[ADP] in beta cells, closing K(ATP) channels and causing depolarization, Ca2+ entry, and insulin release. Decreased responsiveness of K(ATP) channels to elevated [ATP]/[ADP] should therefore lead to decreased insulin secretion and diabetes. To test this critical prediction, we generated transgenic mice expressing beta cell K(ATP) channels with reduced ATP sensitivity. Animals develop severe hyperglycemia, hypoinsulinemia, and ketoacidosis within 2 days and typically die within 5. Nevertheless, islet morphology, insulin localization, and alpha and beta cell distributions were normal (before day 3), pointing to reduced insulin secretion as causal. The data indicate that normal K(ATP) channel activity is critical for maintenance of euglycemia and that overactivity can cause diabetes by inhibiting insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10761930     DOI: 10.1016/s0092-8674(00)80701-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  110 in total

1.  Cellular remodeling in heart failure disrupts K(ATP) channel-dependent stress tolerance.

Authors:  Denice M Hodgson; Leonid V Zingman; Garvan C Kane; Carmen Perez-Terzic; Martin Bienengraeber; Cevher Ozcan; Richard J Gumina; Darko Pucar; Fergus O'Coclain; Douglas L Mann; Alexey E Alekseev; Andre Terzic
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

Review 2.  Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11.

Authors:  Emma L Edghill; Sarah E Flanagan; Sian Ellard
Journal:  Rev Endocr Metab Disord       Date:  2010-09       Impact factor: 6.514

3.  Defects in beta cell Ca²+ signalling, glucose metabolism and insulin secretion in a murine model of K(ATP) channel-induced neonatal diabetes mellitus.

Authors:  R K P Benninger; M S Remedi; W S Head; A Ustione; D W Piston; C G Nichols
Journal:  Diabetologia       Date:  2011-01-27       Impact factor: 10.122

4.  ATP-dependent interaction of the cytosolic domains of the inwardly rectifying K+ channel Kir6.2 revealed by fluorescence resonance energy transfer.

Authors:  Takashi Tsuboi; Jonathan D Lippiat; Frances M Ashcroft; Guy A Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-17       Impact factor: 11.205

5.  Kir6.2 is required for adaptation to stress.

Authors:  Leonid V Zingman; Denice M Hodgson; Peter H Bast; Garvan C Kane; Carmen Perez-Terzic; Richard J Gumina; Darko Pucar; Martin Bienengraeber; Petras P Dzeja; Takashi Miki; Susumu Seino; Alexey E Alekseev; Andre Terzic
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

Review 6.  Molecular defects in insulin secretion in type-2 diabetes.

Authors:  Frances M Ashcroft; Patrik Rorsman
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

Review 7.  Muscle KATP channels: recent insights to energy sensing and myoprotection.

Authors:  Thomas P Flagg; Decha Enkvetchakul; Joseph C Koster; Colin G Nichols
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

Review 8.  The role of the KATP channel in glucose homeostasis in health and disease: more than meets the islet.

Authors:  James S McTaggart; Rebecca H Clark; Frances M Ashcroft
Journal:  J Physiol       Date:  2010-06-02       Impact factor: 5.182

9.  Differential roles for SUR subunits in KATP channel membrane targeting and regulation.

Authors:  Thomas J Hund; Peter J Mohler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-05       Impact factor: 4.733

10.  FoxO1 and SIRT1 regulate beta-cell responses to nitric oxide.

Authors:  Katherine J Hughes; Gordon P Meares; Polly A Hansen; John A Corbett
Journal:  J Biol Chem       Date:  2011-01-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.